Actavia Life Sciences, Inc.
RASP · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,443 | -$687 | -$785 | -$5,347 |
| Dep. & Amort. | $0 | $0 | $0 | $2 |
| Deferred Tax | $0 | $0 | -$91 | -$3 |
| Stock-Based Comp. | $0 | $0 | $43 | $135 |
| Change in WC | $371 | $71 | -$124 | $48 |
| Other Non-Cash | $4,063 | $303 | $663 | $4,914 |
| Operating Cash Flow | -$9 | -$313 | -$293 | -$251 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $44 | $341 | $290 | $216 |
| Stock Issued | $3,859 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $44 | $341 | $290 | $216 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $36 | $29 | -$3 | -$36 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $11 | $14 | $50 |
| End Cash | $75 | $39 | $11 | $14 |
| Free Cash Flow | -$9 | -$313 | -$293 | -$251 |